Table 2.
Cytokines examined | No DLI† | i.v.-DLI | IBM-DLI | T cells with ConA‡ |
---|---|---|---|---|
IL-2 | 0·47 ± 0·3§ | 0·31 ± 0·2 | 0·47 ± 0·3 | 8·51 ± 6·1 |
IL-4 | 0 | 0 | 0·025 ± 0·03 | 1277·2 ± 357·4 |
IL-10 | 0 | 0 | 2·7 ± 2·3 | 95 000 ± 16 000 |
IL-15 | 0 | 0 | 0 | n.d. |
Culture expanded bone marrow stromal cells (BMSCs) from the recipients of intrabone marrow-bone marrow transplantation (IBM-BMT) + IBM-donor lymphocyte infusion (DLI), IBM-BMT + intravenous (i.v.)-DLI, or IBM-BMT alone (without DLI) were used for analysis of cytokine messages by real-time RT–PCR. After DNase I treatment, cDNA was synthesized, amplified using interleukin (IL)-2, IL-4, IL-10 or IL-15 primer, and visualized with SYBR Green by real-time RT–PCR.
Splenic T cells from BALB/c mice were activated with concanavalin A (ConA) and used as a positive control.
Relative intensities of soluble factors were calculated on the basis of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA. Numbers in the table represent mean intensities of cytokines ± standard deviation of three mice (separately cultured BMSCs obtained from the recipient). We performed two separate experiments. n.d., not done.